IBDEI0ZT ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16154,2)
;;=^5002481
;;^UTILITY(U,$J,358.3,16155,0)
;;=E05.01^^61^768^38
;;^UTILITY(U,$J,358.3,16155,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16155,1,3,0)
;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
;;^UTILITY(U,$J,358.3,16155,1,4,0)
;;=4^E05.01
;;^UTILITY(U,$J,358.3,16155,2)
;;=^5002482
;;^UTILITY(U,$J,358.3,16156,0)
;;=E05.90^^61^768^41
;;^UTILITY(U,$J,358.3,16156,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16156,1,3,0)
;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
;;^UTILITY(U,$J,358.3,16156,1,4,0)
;;=4^E05.90
;;^UTILITY(U,$J,358.3,16156,2)
;;=^5002492
;;^UTILITY(U,$J,358.3,16157,0)
;;=E05.91^^61^768^40
;;^UTILITY(U,$J,358.3,16157,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16157,1,3,0)
;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
;;^UTILITY(U,$J,358.3,16157,1,4,0)
;;=4^E05.91
;;^UTILITY(U,$J,358.3,16157,2)
;;=^5002493
;;^UTILITY(U,$J,358.3,16158,0)
;;=E89.0^^61^768^32
;;^UTILITY(U,$J,358.3,16158,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16158,1,3,0)
;;=3^Postprocedural Hypothyroidism
;;^UTILITY(U,$J,358.3,16158,1,4,0)
;;=4^E89.0
;;^UTILITY(U,$J,358.3,16158,2)
;;=^5003035
;;^UTILITY(U,$J,358.3,16159,0)
;;=E03.2^^61^768^13
;;^UTILITY(U,$J,358.3,16159,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16159,1,3,0)
;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
;;^UTILITY(U,$J,358.3,16159,1,4,0)
;;=4^E03.2
;;^UTILITY(U,$J,358.3,16159,2)
;;=^5002471
;;^UTILITY(U,$J,358.3,16160,0)
;;=E03.9^^61^768^14
;;^UTILITY(U,$J,358.3,16160,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16160,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,16160,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,16160,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,16161,0)
;;=E06.0^^61^768^36
;;^UTILITY(U,$J,358.3,16161,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16161,1,3,0)
;;=3^Thyroiditis,Acute
;;^UTILITY(U,$J,358.3,16161,1,4,0)
;;=4^E06.0
;;^UTILITY(U,$J,358.3,16161,2)
;;=^2692
;;^UTILITY(U,$J,358.3,16162,0)
;;=E06.1^^61^768^37
;;^UTILITY(U,$J,358.3,16162,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16162,1,3,0)
;;=3^Thyroiditis,Subacute
;;^UTILITY(U,$J,358.3,16162,1,4,0)
;;=4^E06.1
;;^UTILITY(U,$J,358.3,16162,2)
;;=^119376
;;^UTILITY(U,$J,358.3,16163,0)
;;=C73.^^61^768^19
;;^UTILITY(U,$J,358.3,16163,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16163,1,3,0)
;;=3^Malig Neop of Thyroid Gland
;;^UTILITY(U,$J,358.3,16163,1,4,0)
;;=4^C73.
;;^UTILITY(U,$J,358.3,16163,2)
;;=^267296
;;^UTILITY(U,$J,358.3,16164,0)
;;=E16.2^^61^768^10
;;^UTILITY(U,$J,358.3,16164,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16164,1,3,0)
;;=3^Hypoglycemia,Unspec
;;^UTILITY(U,$J,358.3,16164,1,4,0)
;;=4^E16.2
;;^UTILITY(U,$J,358.3,16164,2)
;;=^5002708
;;^UTILITY(U,$J,358.3,16165,0)
;;=E20.0^^61^768^15
;;^UTILITY(U,$J,358.3,16165,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16165,1,3,0)
;;=3^Idiopathic Hypoparathyroidism
;;^UTILITY(U,$J,358.3,16165,1,4,0)
;;=4^E20.0
;;^UTILITY(U,$J,358.3,16165,2)
;;=^5002712
;;^UTILITY(U,$J,358.3,16166,0)
;;=E20.9^^61^768^11
;;^UTILITY(U,$J,358.3,16166,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16166,1,3,0)
;;=3^Hypoparathyroidism,Unspec
;;^UTILITY(U,$J,358.3,16166,1,4,0)
;;=4^E20.9
;;^UTILITY(U,$J,358.3,16166,2)
;;=^5002714
;;^UTILITY(U,$J,358.3,16167,0)
;;=E23.0^^61^768^12
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0ZT 3760 printed Sep 23, 2025@19:34:58 Page 2
IBDEI0ZT ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16154,2)
+2 ;;=^5002481
+3 ;;^UTILITY(U,$J,358.3,16155,0)
+4 ;;=E05.01^^61^768^38
+5 ;;^UTILITY(U,$J,358.3,16155,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,16155,1,3,0)
+8 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
+9 ;;^UTILITY(U,$J,358.3,16155,1,4,0)
+10 ;;=4^E05.01
+11 ;;^UTILITY(U,$J,358.3,16155,2)
+12 ;;=^5002482
+13 ;;^UTILITY(U,$J,358.3,16156,0)
+14 ;;=E05.90^^61^768^41
+15 ;;^UTILITY(U,$J,358.3,16156,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,16156,1,3,0)
+18 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
+19 ;;^UTILITY(U,$J,358.3,16156,1,4,0)
+20 ;;=4^E05.90
+21 ;;^UTILITY(U,$J,358.3,16156,2)
+22 ;;=^5002492
+23 ;;^UTILITY(U,$J,358.3,16157,0)
+24 ;;=E05.91^^61^768^40
+25 ;;^UTILITY(U,$J,358.3,16157,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,16157,1,3,0)
+28 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
+29 ;;^UTILITY(U,$J,358.3,16157,1,4,0)
+30 ;;=4^E05.91
+31 ;;^UTILITY(U,$J,358.3,16157,2)
+32 ;;=^5002493
+33 ;;^UTILITY(U,$J,358.3,16158,0)
+34 ;;=E89.0^^61^768^32
+35 ;;^UTILITY(U,$J,358.3,16158,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,16158,1,3,0)
+38 ;;=3^Postprocedural Hypothyroidism
+39 ;;^UTILITY(U,$J,358.3,16158,1,4,0)
+40 ;;=4^E89.0
+41 ;;^UTILITY(U,$J,358.3,16158,2)
+42 ;;=^5003035
+43 ;;^UTILITY(U,$J,358.3,16159,0)
+44 ;;=E03.2^^61^768^13
+45 ;;^UTILITY(U,$J,358.3,16159,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,16159,1,3,0)
+48 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
+49 ;;^UTILITY(U,$J,358.3,16159,1,4,0)
+50 ;;=4^E03.2
+51 ;;^UTILITY(U,$J,358.3,16159,2)
+52 ;;=^5002471
+53 ;;^UTILITY(U,$J,358.3,16160,0)
+54 ;;=E03.9^^61^768^14
+55 ;;^UTILITY(U,$J,358.3,16160,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,16160,1,3,0)
+58 ;;=3^Hypothyroidism,Unspec
+59 ;;^UTILITY(U,$J,358.3,16160,1,4,0)
+60 ;;=4^E03.9
+61 ;;^UTILITY(U,$J,358.3,16160,2)
+62 ;;=^5002476
+63 ;;^UTILITY(U,$J,358.3,16161,0)
+64 ;;=E06.0^^61^768^36
+65 ;;^UTILITY(U,$J,358.3,16161,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,16161,1,3,0)
+68 ;;=3^Thyroiditis,Acute
+69 ;;^UTILITY(U,$J,358.3,16161,1,4,0)
+70 ;;=4^E06.0
+71 ;;^UTILITY(U,$J,358.3,16161,2)
+72 ;;=^2692
+73 ;;^UTILITY(U,$J,358.3,16162,0)
+74 ;;=E06.1^^61^768^37
+75 ;;^UTILITY(U,$J,358.3,16162,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,16162,1,3,0)
+78 ;;=3^Thyroiditis,Subacute
+79 ;;^UTILITY(U,$J,358.3,16162,1,4,0)
+80 ;;=4^E06.1
+81 ;;^UTILITY(U,$J,358.3,16162,2)
+82 ;;=^119376
+83 ;;^UTILITY(U,$J,358.3,16163,0)
+84 ;;=C73.^^61^768^19
+85 ;;^UTILITY(U,$J,358.3,16163,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,16163,1,3,0)
+88 ;;=3^Malig Neop of Thyroid Gland
+89 ;;^UTILITY(U,$J,358.3,16163,1,4,0)
+90 ;;=4^C73.
+91 ;;^UTILITY(U,$J,358.3,16163,2)
+92 ;;=^267296
+93 ;;^UTILITY(U,$J,358.3,16164,0)
+94 ;;=E16.2^^61^768^10
+95 ;;^UTILITY(U,$J,358.3,16164,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,16164,1,3,0)
+98 ;;=3^Hypoglycemia,Unspec
+99 ;;^UTILITY(U,$J,358.3,16164,1,4,0)
+100 ;;=4^E16.2
+101 ;;^UTILITY(U,$J,358.3,16164,2)
+102 ;;=^5002708
+103 ;;^UTILITY(U,$J,358.3,16165,0)
+104 ;;=E20.0^^61^768^15
+105 ;;^UTILITY(U,$J,358.3,16165,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,16165,1,3,0)
+108 ;;=3^Idiopathic Hypoparathyroidism
+109 ;;^UTILITY(U,$J,358.3,16165,1,4,0)
+110 ;;=4^E20.0
+111 ;;^UTILITY(U,$J,358.3,16165,2)
+112 ;;=^5002712
+113 ;;^UTILITY(U,$J,358.3,16166,0)
+114 ;;=E20.9^^61^768^11
+115 ;;^UTILITY(U,$J,358.3,16166,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,16166,1,3,0)
+118 ;;=3^Hypoparathyroidism,Unspec
+119 ;;^UTILITY(U,$J,358.3,16166,1,4,0)
+120 ;;=4^E20.9
+121 ;;^UTILITY(U,$J,358.3,16166,2)
+122 ;;=^5002714
+123 ;;^UTILITY(U,$J,358.3,16167,0)
+124 ;;=E23.0^^61^768^12
